Szabolcs Fatrai

Scientist Translational Research at Merus

The Randstad, Netherlands

About

Experience

  • Senior Translational Scientist at Genmab
    Dec 2025 - Present · 7 mos

  • Merus N.V. (Utrecht, Netherlands · Hybrid)
    • Senior Translational Scientist
      Jan 2025 - Dec 2025 · 1 yr

    • Scientist Translational Research
      Nov 2017 - Dec 2024 · 7 yrs 2 mos

  • Postdoctoral Researcher at Erasmus MC
    2015 - 2017 · 2 yrs

    Department of Hematology Advisor: Professor Dr. Ivo Touw - Investigating the role of RUNX1 and G-CSFR mutations in the development of acute myeloid leukemia using in vitro and in vivo model systems

  • Postdoctoral Researcher at UMC Utrecht
    2010 - 2014 · 4 yrs

    Laboratory of Experimental Oncology, Department of Surgery Advisor: Professor Dr. Inne Borel Rinkes and Professor Dr. Onno Kranenburg – Identifying cKIT-SCF signaling as a novel mechanism that promotes EMT in colorectal cancer – Studying the effect of cKIT inhibition on EMT and tumor initiation – Developing co-cultures to study epithelial-mesenchymal transition (EMT) in colorectal cancer – Establishing spheroid and organoid cultures from primary colorectal tumors

  • PhD student at University Medical Center Groningen
    2005 - 2010 · 5 yrs

    Department of Hematology – Identifying novel STAT5 target genes in hematopoietic stem and progenitor cells that are involved in STAT5 induced stem cell self-renewal and long-term expansion – Studying the oncogenic KRAS induced phenotypes and signaling pathways in hematopoietic cells and identifying angiopoietin-like 6 as an important secreted factor that enhances proliferation in human CD34+ cord blood cells